Characterization of sarcoma cell lines from v-jun transgenic mice

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Wounding is a critical initial step for tumor development in v-jun transgenic mice.
• Tumor progression involves a multistep process with variable transgene mRNA expression in tumor tissues.
• Heterogeneous v-jun transgene expression is observed in individual sarcoma cells.

Purpose of the Study:

• To investigate the relationship between cellular growth properties and the expression or function of the v-jun transgene.
• To determine if v-jun expression levels correlate with the transformed phenotype in cloned cell lines.
• To understand the role of v-jun in tumor formation and progression.

Main Methods:

• Cloning of cell lines from wound-related v-jun transgenic tumors.
• Assessing cloning efficiency in soft agar and tumorigenicity in nude mice.
• Analyzing v-jun mRNA and protein expression, activator protein 1 DNA binding activity, and endogenous c-jun expression.
• Transfection experiments to evaluate the effect of v-jun expression vector.

Main Results:

• Cell lines with high v-jun expression exhibited high cloning efficiency and tumorigenicity.
• No correlation was found between intermediate/low v-jun expression and the transformed phenotype, morphology, growth rate, or copy number.
• Tumor cell subclones with low v-jun expression showed reduced activator protein 1 DNA binding and increased endogenous c-jun.
• Overexpression of v-jun enhanced in vitro cloning and in vivo tumor formation in susceptible cell lines.

Conclusions:

• v-jun transgene expression is a contributing factor to the transformed phenotype of tumor cell lines.
• Additional factors beyond v-jun expression influence the growth properties of tumor cells in vitro and in vivo.
• The study highlights the complex interplay of genetic and cellular factors in tumor development initiated by wounding.